Children as young as five could soon be given the Pfizer coronavirus vaccine, with the company set to submit trial data to regulators “this month”. Jabs for babies to follow next spring.
The pharmaceutical giant announced in March that it had launched a series of clinical trials to test two doses of its vaccine, developed with the German firm BioNTech, in children as young as six months old.
According to Pfizer’s chief executive, Dr Albert Bourla, results from the older cohort of participants – aged between five and 11 – are set to be submitted to regulators before the end of September. Astonishingly Bourla claimed “We know that the vaccine works very well in young kids,” telling journalists on Tuesday. “We are working also to submit data from five to 11 [year olds] this month.”
Reports from the New York Times suggest results for children aged between two and five are expected shortly afterwards, while data on infants aged between six months and two years could be submitted in October or November.
It is likely that, in line with Pfizer's approach to approval for the booster shots, the data on five to 11 year olds will first be submitted to the US Food and Drug Administration. Even more astonishingly the pharmaceuticals giant state that the trial tested a two shot regimen 21 days apart, but with a slightly smaller dosage – 10 micrograms, rather than the 30 micrograms used in children and adults over 12. Dr Bourla’s comments will do nothing to quell the growing anger shown by millions of parents who are aware of the shocking safety record of this new generation of vaccines. Even the UK’s Joint Committee on Vaccinations and Immunisations (JCVI) has advised against vaccinating healthy children, and this is even after 3 members were sacked for not towing the SAGE line. For healthy children, the committee argued, the benefits of a jab only “marginally” outweigh the risks, and the longer term impacts remain hazy.
Elsewhere experts not in the pay of big pharma have been raising the alarm over myocarditis, a potentially fatal swelling of the heart muscle that has been repeatedly linked to the Vaccine.
Dr Clare Craig a Consultant Pathologist and Covid expert has stated that the data shows the younger the child the greater the risk of myocarditis and that its onset happens soon after the first dose.
But during Tuesday’s briefing, hosted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Dr Bourla said the science supports vaccinating children. He stated: “It is not my role to say who should be receiving doses,” he said. “But what I can say, clearly, is that younger ages are getting sick... the percentage of people that will get severe [Covid] in older ages is higher than in younger, but this [risk] is not zero."
This was nothing but hyperbole, Dr Bourla didn't back-up these claims with any evidence or data, but was allowed to continue saying: “The other thing that we need to understand is that kids attend school. And because of that, the kids have much higher probability [of getting] infected, as they socialise in high proximity with other kids."
“We know that the vaccines work very well in young kids,” Dr Bourla said, adding that the Pfizer shot has already been approved in children over 12 in much of the world.
Remember, there is absolutely no clinical reason for children to have this vaccine, despite the sales pitch from Pfizer, the overwhelming evidence shows that Coronavirus is not a threat to children. It has also been proven that the vaccine has little or no effect on transmission of the most common variant, the argument for that being a valid reason to give all children the experimental drug has been debunked, repeatedly.
Still think this is about a virus?
Related Articles
